Company news

TrivarX Limited news in 2026

TrivarX Limited's news releases, calls and decks from 2026, newest first.

View company

September 2026 Quarterly Activities Report and Appendix 4C

October 29, 2026

September 2026 Quarterly Activities Report and Appendix 4C

October 29, 2026

Syntro Health Appointed to Support Stabl-Im Clinical Program

October 21, 2026

Syntro Health Appointed to Support Stabl-Im Clinical Program

October 21, 2026

Stabl-Im Clinical Development Update

September 22, 2026

June 2026 Quarterly Activities Report and Appendix 4C

July 28, 2026

Stabl-Im clinical trial supply milestone achieved

July 15, 2026

CRO Engaged to Advance Stabl-Im Phase 1 Trial

May 21, 2026

March 2026 Quarterly Activities Report and Appendix 4C

April 29, 2026

Dr Danielle Meyrick appointed as CEO

April 28, 2026

Appendix 4D & Half-Year Financial Report to 31 December 2025

February 24, 2026

December 2025 Quarterly Activities Report and Appendix 4C

January 29, 2026

Decks in 2026